Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AVELUMAB Cause Platelet count decreased? 30 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Platelet count decreased have been filed in association with AVELUMAB (BAVENCIO). This represents 0.8% of all adverse event reports for AVELUMAB.

30
Reports of Platelet count decreased with AVELUMAB
0.8%
of all AVELUMAB reports
8
Deaths
15
Hospitalizations

How Dangerous Is Platelet count decreased From AVELUMAB?

Of the 30 reports, 8 (26.7%) resulted in death, 15 (50.0%) required hospitalization, and 4 (13.3%) were considered life-threatening.

Is Platelet count decreased Listed in the Official Label?

Yes, Platelet count decreased is listed as a known adverse reaction in the official FDA drug label for AVELUMAB.

What Other Side Effects Does AVELUMAB Cause?

Death (361) Disease progression (355) Off label use (200) Diarrhoea (153) Infusion related reaction (142) Pyrexia (129) Fatigue (124) Neoplasm progression (119) Dyspnoea (100) Nausea (99)

What Other Drugs Cause Platelet count decreased?

LENALIDOMIDE (7,491) NIRAPARIB (4,102) ELTROMBOPAG OLAMINE (3,419) RUXOLITINIB (3,028) RITUXIMAB (2,404) VENETOCLAX (2,367) DEXAMETHASONE (2,321) PALBOCICLIB (2,277) CYCLOPHOSPHAMIDE (1,894) RIBAVIRIN (1,701)

Which AVELUMAB Alternatives Have Lower Platelet count decreased Risk?

AVELUMAB vs AVIBACTAM AVELUMAB vs AVIBACTAM\CEFTAZIDIME AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OCTOCRYLENE\OXYBENZONE\TITANIUM DIOXIDE\ZINC AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE

Related Pages

AVELUMAB Full Profile All Platelet count decreased Reports All Drugs Causing Platelet count decreased AVELUMAB Demographics